Clinical trial
Combination Chemotherapy and Exisulind in Treating Patients With Extensive-Stage…
NCT00041054 · Alliance for Clinical Trials in Oncology, Other · Completed
Key facts
| NCT number | NCT00041054 |
|---|---|
| Title | Combination Chemotherapy and Exisulind in Treating Patients With Extensive-Stage Small Cell Lung Cancer |
| Official title | A Phase II Study of Carboplatin, Etoposide, and Exisulind in Patients With Extensive Small Cell Lung Cancer |
| Lead sponsor | Alliance for Clinical Trials in Oncology, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Lung Cancer |
| Intervention type | Drug |
| Interventions | carboplatin, etoposide, exisulind |
| Enrollment | 41 |
| Start date | Jun 1, 2002 |
| Primary completion | Aug 1, 2004 |
| Completion | Feb 1, 2008 |
| First posted | Jan 27, 2003 |
| Last update posted | Dec 7, 2016 |
| Countries | Canada, Puerto Rico, United States |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: